ANECTINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anectine, and what generic alternatives are available?
Anectine is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in ANECTINE is succinylcholine chloride. There are six drug master file entries for this compound. Thirty suppliers are listed for this compound. Additional details are available on the succinylcholine chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Anectine
A generic version of ANECTINE was approved as succinylcholine chloride by ZYDUS PHARMS on May 4th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANECTINE?
- What are the global sales for ANECTINE?
- What is Average Wholesale Price for ANECTINE?
Summary for ANECTINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,923 |
| Drug Prices: | Drug price information for ANECTINE |
| What excipients (inactive ingredients) are in ANECTINE? | ANECTINE excipients list |
| DailyMed Link: | ANECTINE at DailyMed |
Recent Clinical Trials for ANECTINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Geneva | Phase 2 |
| University of Lausanne Hospitals | Phase 2 |
Pharmacology for ANECTINE
| Drug Class | Depolarizing Neuromuscular Blocker |
| Physiological Effect | Neuromuscular Depolarizing Blockade |
US Patents and Regulatory Information for ANECTINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-002 | Approved Prior to Jan 1, 1982 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sandoz | ANECTINE | succinylcholine chloride | INJECTABLE;INJECTION | 008453-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
